ArticleFrontiers in immunology2023

Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models.

Haider S Mahdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.